Ultragenyx Pharmaceutical Inc.

RARE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 20, 2026
4 Oct 19, 2026 4
8-K Oct 19, 2026 8-K
8-K Oct 14, 2026 8-K
8-K Oct 7, 2026 8-K
8-K Sep 17, 2026 8-K
4 Sep 15, 2026 4
144 Sep 15, 2026
4 Sep 8, 2026 4
8-K Sep 2, 2026 8-K
8-K Aug 19, 2026 8-K
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G Aug 13, 2026
8-K Aug 11, 2026 8-K
SCHEDULE 13G Aug 7, 2026
10-Q Aug 5, 2026 10-Q
8-K Aug 4, 2026 8-K
4 Aug 4, 2026 4
4 Aug 4, 2026 4
144 Aug 3, 2026
SCHEDULE 13G/A Jul 31, 2026
SCHEDULE 13G Jul 31, 2026
SCHEDULE 13G/A Jul 30, 2026
4 Jul 6, 2026 4
144 Jul 1, 2026
← Newer Page 1 of 46 · 1145 filings Older →